XML 65 R54.htm IDEA: XBRL DOCUMENT v3.19.2
Stockholders' Equity (Deficit) (Details Textual) - USD ($)
 1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 12, 2018
Nov. 30, 2018
Oct. 20, 2016
Feb. 28, 2019
Aug. 03, 2018
Jul. 20, 2017
Nov. 30, 2018
Mar. 31, 2019
Mar. 31, 2019
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Mar. 31, 2018
Class of Stock [Line Items]                          
Common stock authorized               100,000,000 100,000,000 100,000,000   100,000,000  
Common stock, par value               $ 0.001 $ 0.001 $ 0.001   $ 0.001  
Common stock, shares issued               12,944,514 12,944,514 9,656,505   7,864,994  
Common stock, shares outstanding               12,944,514 12,944,514 9,656,505   7,864,994  
Preferred stock, par value               $ 0.001 $ 0.001 $ 0.001   $ 0.001  
Preferred stock, shares authorized               10,000,000 10,000,000 10,000,000   10,000,000  
Purchase agreement, description             The Company issued and sold an aggregate of 170,000 additional Units to the Purchasers, for total gross proceeds to the Company of approximately $425,000 before deducting offering expenses.            
Aggregrate sale of shares                   445,200      
Deducting offering expenses                   $ 1,113,000      
Maximum shares issuable with over-allotment under private placement         4,600,000                
Risk free interest rate                   2.80% 1.90%    
Expected stock price volatility                   49.80% 47.80%    
Expected life of options (years)                   5 years 5 years    
Expected dividend yield                   0.00% 0.00%    
Acquired percentage           100.00%              
Aggregate shares issued of the then-outstanding NeuroOne shares           3,500,000              
Subsidiaries [Member]                          
Class of Stock [Line Items]                          
Common stock, shares issued     5,131,514                    
Exercise price, per share     $ 0.03                    
Acquired percentage           100.00%              
Aggregate shares issued of the then-outstanding NeuroOne shares           6,291,994              
Net exchanges of shares           1,573,000              
Subscription receivable     $ 9,050                    
Warrant [Member]                          
Class of Stock [Line Items]                          
Warrants exercisable, term         5 years                
Common Stock [Member]                          
Class of Stock [Line Items]                          
Maximum offering of units under private placement         4,000,000                
Net exchanges of shares                       859,976  
Private Placement [Member]                          
Class of Stock [Line Items]                          
Purchase agreement, description         (i) 1 share (each, a "Share") of the Company's common stock and (ii) a warrant to purchase 1 share of common stock at an initial exercise price of $3.00 per share (the "2018 Warrants").                
Maximum offering of units under private placement         4,000,000                
Offering price, per share         $ 2.50                
Cash commission, percentage         10.00%                
Exercise price, per share         $ 3.45                
Common stock purchase price, per share         10.00%                
Warrants exercisable, term         5 years                
Private placement transaction, description (i) 1 share of common stock and (ii) a warrant to purchase 1 share of common stock at an initial exercise price of $3.00 per share (the "2019 Warrants"), to the New Purchasers.                        
Broker warrants liability                   $ 26,878      
2018 Private Placement [Member]                          
Class of Stock [Line Items]                          
Purchase agreement, description   (i) 1 share (each, a “Share”) of common stock and (ii) a warrant to purchase 1 share of common stock at an initial exercise price of $3.00 per share (the “2018 Warrants”).                      
Warrant issued               40,416 40,416        
Risk free interest rate                 2.90%        
Expected stock price volatility                 49.80%        
Expected life of options (years)                 4 years 7 months 6 days        
Expected dividend yield                 0.00%        
Cost of issuance                   173,067      
Cash commission, percentage                 8.00%        
Exercise price, per share                 $ 3.00        
Common stock purchase price, per share                 8.00%        
Warrants exercisable, term               5 years 5 years        
Legal costs                   $ 62,389      
Acquired percentage       10.00%                  
Units sold under private placement               0 170,000        
Gross proceeds from private placement $ 1,538,000                        
Fair value of warrant issued                 $ 115,674        
Private placement transaction, description       The Company and HRA agreed (i) to extend the Tail Period until June 30, 2019, (ii) to modify the HRA Fee so that HRA is entitled to receive a cash fee equal to 8% of the gross proceeds received by the Company from Prospects in all subsequent private placement transactions and (iii) to modify the HRA Warrants so that they are exercisable to purchase shares of Common Stock (or common stock equivalents) in an amount equal to 8% of the shares of Common Stock purchased by Prospects in subsequent private placements (collectively, the “HRA Amendments”). Upon issuance, the HRA Warrants will be immediately exercisable and expire five years from the closing of the related transaction.                  
Shares issued under private placement 615,200                        
Credit adjustment amount related to HRA commission               $ 24,029 35,665        
Legal costs related to private placement issuance costs                 7,340        
Brokerage commission                 17,240        
Commission liability               $ 11,085 $ 11,085        
2018 Private Placement [Member] | Warrant [Member]                          
Class of Stock [Line Items]                          
Warrant issued                         221,074
2019 Private Placement [Member]                          
Class of Stock [Line Items]                          
Purchase agreement, description                 (i) 1 share of common stock and (ii) a warrant to purchase 1 share of common stock at an initial exercise price of $3.00 per share (the “2019 Warrants”).        
Risk free interest rate                 2.50%        
Expected stock price volatility                 50.60%        
Expected life of options (years)                 4 years 9 months 18 days        
Expected dividend yield                 0.00%        
Cash commission, percentage                 8.00%        
Exercise price, per share                 $ 3.00        
Common stock purchase price, per share                 10.00%        
Warrants exercisable, term               5 years 5 years        
Units sold under private placement               1,743,979 1,903,979        
Gross proceeds from private placement                 $ 4,759,948        
Estimated fair value of the broker warrants to be issued                 $ 179,643        
Broker warrants to be issued shares                 180,658        
Fair value of warrant issued               $ 1,193,564 $ 1,301,241        
Direct offset to proceeds from the private placement               $ 722,806 812,428        
Cash commissions amounting                 561,294        
Commission fees related to financing                 $ 71,491        
2019 Private Placement [Member] | Paulson [Member]                          
Class of Stock [Line Items]                          
Cash commission, percentage                 12.00%        
Warrants exercisable, term               5 years 5 years        
Private placement transaction, description                 HRA will receive a cash commission equal to 8% of the gross proceeds from the sale of the 2019 Units sold by HRA. In addition to the brokers' commission, the Company will issue 5-year warrants to HRA to purchase an amount of Common Stock equal to 8% of the total amount of Shares sold by HRA in the 2019 Private Placement at an exercise price of $3.00 per share.        
2019 Private Placement [Member] | Warrant [Member]                          
Class of Stock [Line Items]                          
Maximum shares issuable under private placement                 4,000,000        
Maximum potential gross proceeds from financing                 $ 10,000,000        
Stock unit price per unit               $ 2.50 $ 2.50        
2019 Private Placement [Member] | Warrant [Member] | Minimum [Member]                          
Class of Stock [Line Items]                          
Stock unit price per unit               2.75 2.75        
2019 Private Placement [Member] | Warrant [Member] | Maximum [Member]                          
Class of Stock [Line Items]                          
Stock unit price per unit               $ 3.00 $ 3.00        
Over-Allotment Option [Member]                          
Class of Stock [Line Items]                          
Maximum offering, units         600,000